Aspire Biopharma Holdings, Inc. filed a Form 8-K to announce the distribution of a new investor presentation, dated August 19, 2026.
Key Details
- Filing Item: The disclosure was made under Item 7.01, Regulation FD Disclosure.
- Exhibit: The investor presentation was furnished as Exhibit 99.1 to the filing.
- Content Note: The specific contents of the presentation were provided in an image-based format and were not available as text within the filing.